The University of Chicago Header Logo

Kathleen Mullane

TitleClinical Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Infectious Diseases
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cordonnier C, Velez JD, Ljungman P, Maertens J, Selleslag D, Nabhan S, Richmond P, Wilck M, Cornely OA, Mullane KM, Chen Q, Dagan R, Daus C, Geddie K, Tamms G, Sterling T, Patel SM, Shekar T, Musey L, Buchwald UK, V114-022 (PNEU-STEM) Study Group. A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clin Infect Dis. 2023 10 13; 77(8):1102-1110. PMID: 37338158; PMCID: PMC10573722.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Ariza-Heredia EJ, Winston DJ, Rowley SD, Mullane K, Chandrasekar P, Hari P, Avery RK, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, El Haddad L, Shah DP, Jiang Y, Khawaja F, Dadwal S, Blanchard T, Chemaly RF. Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant. Open Forum Infect Dis. 2023 Aug; 10(8):ofad386. PMID: 37636519; PMCID: PMC10460252.
    3. Alonso CD, Maron G, Kamboj M, Carpenter PA, Gurunathan A, Mullane KM, Dubberke ER. American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients. Transplant Cell Ther. 2022 05; 28(5):225-232. PMID: 35202891.
      Citations: 1     Fields:    Translation:Humans
    4. Pajon R, Paila YD, Girard B, Dixon G, Kacena K, Baden LR, El Sahly HM, Essink B, Mullane KM, Frank I, Denhan D, Kerwin E, Zhao X, Ding B, Deng W, Tomassini JE, Zhou H, Leav B, COVE Trial Consortium, Schödel F. Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial. Nat Med. 2022 04; 28(4):823-830. PMID: 35145311; PMCID: PMC9018421.
      Citations: 15     Fields:    Translation:HumansCellsCTClinical Trials
    5. Pettit NN, Pisano J, Nguyen CT, Lew AK, Hazra A, Sherer R, Mullane KM. Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk? Clin Infect Dis. 2021 12 06; 73(11):e3990-e3995. PMID: 33315065; PMCID: PMC7799321.
      Citations: 27     Fields:    Translation:HumansCells
    6. Olender SA, Walunas TL, Perez KK, Castagna A, Wang S, Kurbegov D, Goyal P, Ripamonti D, Balani B, De Rosa FG, Kim SW, Diaz G, Bruno R, Mullane KM, Lye DC, Gottlieb RL, Haubrich RH, Chokkalingam AP, Wu G, Diaz-Cuervo H, Brainard DM, Lee IH, Hu H, Lin L, Osinusi AO, Bernardino JI, Boffito M, Martinez E, De Wit S. Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality. Open Forum Infect Dis. 2021 Jul; 8(7):ofab278. PMID: 34282406; PMCID: PMC8244650.
      Citations: 18     
    7. Olson G, McNulty MC, Mullane K, Beavis KG, Tesic V. Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient. Lab Med. 2021 May 04; 52(3):e50-e52. PMID: 32954440.
      Citations: 1     Fields:    Translation:HumansCells
    8. Chemaly RF, Dadwal SS, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M, Bergeron A, Lachance S. A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients. Clin Infect Dis. 2020 12 31; 71(11):2777-2786. PMID: 31793991; PMCID: PMC7108134.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    9. Marty FM, Chemaly RF, Mullane KM, Lee DG, Hirsch HH, Small CB, Shoham S, Ljungman P, Waghmare A, Blanchard E, Kim YJ, McKevitt M, Porter DP, Jordan R, Guo Y, German P, Boeckh M, Watkins TR, Chien JW, Dadwal SS, Bergeron A. A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract. Clin Infect Dis. 2020 12 31; 71(11):2787-2795. PMID: 31915807; PMCID: PMC7108198.
      Citations: 19     Fields:    Translation:Humans
    10. Spinner CD, Gottlieb RL, Criner GJ, Cattelan AM, Soriano Viladomiu A, Ogbuagu O, Malhotra P, Mullane KM, Castagna A, Chai LYA, Roestenberg M, Tsang OTY, Bernasconi E, Le Turnier P, Chang SC, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wang H, Gaggar A, Brainard DM, McPhail MJ, Bhagani S, Ahn MY, Sanyal AJ, Huhn G, Marty FM, GS-US-540-5774 Investigators, Arribas López JR. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 09 15; 324(11):1048-1057. PMID: 32821939; PMCID: PMC7442954.
      Citations: 568     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    11. Derman BA, Schlei Z, Parsad S, Mullane K, Knoebel RW. Changes in Intravenous Immunoglobulin Usage for Hypogammaglobulinemia After Implementation of a Stewardship Program. JCO Oncol Pract. 2021 03; 17(3):e445-e453. PMID: 32822257; PMCID: PMC8257910.
      Citations: 4     Fields:    Translation:Humans
    12. Koehler P, Kindo A, Falces-Romero I, Chen SC, Klimko N, Thompson GR, Sheppard DC, Hoenigl M, Le Govic Y, Badali H, Baddley JW, Chander J, Ingram PR, Pakstis DL, Mellinghoff SC, Atici S, Cesaro S, Chakrabarti A, Klyasova G, Mullane K, Vinh DC, Wisplinghoff H, Lackner M, Seidel D, ECMM/ISHAM working group, Salmanton-García J, García-Rodríguez J, Rácil Z, Desoubeaux G, Benítez-Peñuela MÁ, Rodríguez JY, Dupont D, González GM, Hatvani L, Herbrecht R, Lass-Flörl C, Cornely OA, Mare? M. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope?-Global Registry for Emerging Fungal Infections. J Infect. 2020 11; 81(5):802-815. PMID: 32798532.
      Citations: 12     Fields:    Translation:Humans
    13. Boeckh MJ, Arvin AM, Mullane KM, Camacho LH, Winston DJ, Morrison VA, Hurtado K, Durrand Hall J, Pang L, Su SC, Kaplan SS, Annunziato PW, Popmihajlov Z, V212 Protocol 001 Trial Group and V212 Protocol 011 Trial Group. Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa172. PMID: 32665955; PMCID: PMC7336559.
      Citations: 3     
    14. GS-US-540-5773 Investigators, Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Muñoz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 11 05; 383(19):1827-1837. PMID: 32459919; PMCID: PMC7377062.
      Citations: 633     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    15. Mullane KM, Birch T, Hazan-Steinberg S, Nathan R, Bouza E, Calfee DP, Ellison MC, Wong MT, Dorr MB, Cornely OA. Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer. Open Forum Infect Dis. 2020 Feb; 7(2):ofaa038. PMID: 32099847; PMCID: PMC7029680.
      Citations: 4     
    16. Mullane KM, Morrison VA, Camacho LH, Arvin A, McNeil SA, Durrand J, Campbell B, Su SC, Chan ISF, Parrino J, Kaplan SS, Popmihajlov Z, Annunziato PW, V212 Protocol 011 Trial Team. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2019 09; 19(9):1001-1012. PMID: 31399378.
      Citations: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    17. Mullane KM, Dubberke ER, AST ID Community of Practice. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice. Clin Transplant. 2019 09; 33(9):e13564. PMID: 31002420.
      Citations: 8     Fields:    Translation:HumansCells
    18. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P, Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis. 2019 04 08; 68(8):1420-1426. PMID: 30137245; PMCID: PMC7348585.
      Citations: 49     Fields:    Translation:Humans
    19. Mullane KM, Winston DJ, Nooka A, Morris MI, Stiff P, Dugan MJ, Holland H, Gregg K, Adachi JA, Pergam SA, Alexander BD, Dubberke ER, Broyde N, Gorbach SL, Sears PS. A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2019 01 07; 68(2):196-203. PMID: 29893798; PMCID: PMC6321849.
      Citations: 15     Fields:    Translation:HumansCells
    20. McNulty MC, Shibib DR, Steinbeck JL, Mullane K, Pisano J, Matushek S, Beavis KG, Tesic V, Pitrak D. Misdiagnosis of Bordetella bronchiseptica Respiratory Infection as Bordetella pertussis by Multiplex Molecular Assay. Clin Infect Dis. 2018 11 28; 67(12):1919-1921. PMID: 29860317.
      Citations: 5     Fields:    Translation:HumansCells
    21. Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ, SUPPRESS Trial Clinical Study Group. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381. PMID: 30292744; PMCID: PMC8196624.
      Citations: 66     Fields:    Translation:HumansCellsCTClinical Trials
    22. Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G, Cornely OA. Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018 Aug; 61(8):518-533. PMID: 29611246.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    23. Winston DJ, Mullane KM, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Craig MD, Papanicolaou GA, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, Kaplan SS, Parrino J, Lee I, Popmihajlov Z, Annunziato PW, Arvin A, V212 Protocol 001 Trial Team, Cornely OA, Žák P, Velez JD. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018 05 26; 391(10135):2116-2127. PMID: 29856344.
      Citations: 31     Fields:    Translation:Humans
    24. Marty FM, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Oren I, Schmitt-Hoffmann AH, Giladi M, Rahav G, Perfect JR, Cornely OA. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses. 2018 Jul; 61(7):485-497. PMID: 29611227.
      Citations: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
    25. Perfect JR, Heep M, Ostrosky-Zeichner L, Mullane KM, Maher R, Croos-Dabrera R, Lademacher C, Engelhardt M, Chen C, Marty FM, Cornely OA. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses. 2018 Jul; 61(7):420-429. PMID: 29570857; PMCID: PMC6490690.
      Citations: 13     Fields:    Translation:HumansAnimals
    26. Kontoyiannis DP, Selleslag D, Mullane K, Hope W, Croos-Dabrera R, Lademacher C, Engelhardt M, Patterson TF, Cornely OA, Lortholary O. Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763. PMID: 29194488.
      Citations: 22     Fields:    Translation:HumansAnimalsCTClinical Trials
    27. Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. 2017 12 21; 377(25):2433-2444. PMID: 29211658.
      Citations: 314     Fields:    Translation:HumansCellsCTClinical Trials
    28. Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Raad I, Meyer RG, Hammond SP, Mullane KM, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J, Cornely OA, Heinz WJ, Schanz U, Ostermann H, Ullmann AJ. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 Dec 01; 72(12):3406-3413. PMID: 28961714.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    29. Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J. Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J Antimicrob Chemother. 2017 12 01; 72(12):3501. PMID: 29029280.
      Citations: 5     Fields:    
    30. Weaver FM, Trick WE, Evans CT, Lin MY, Adams W, Pho MT, Bleasdale SC, Mullane KM, Johnson S, Sikka MK, Peterson LR, Solomonides AE, Gerding DN. The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors. Infect Control Hosp Epidemiol. 2017 11; 38(11):1351-1357. PMID: 28946934.
      Citations: 4     Fields:    Translation:HumansCells
    31. Revankar SG, Baddley JW, Chen SC, Kauffman CA, Slavin M, Vazquez JA, Seas C, Morris MI, Nguyen MH, Shoham S, Thompson GR, Alexander BD, Simkins J, Ostrosky-Zeichner L, Mullane K, Alangaden G, Andes DR, Cornely OA, Wahlers K, Lockhart SR, Pappas PG. A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases. Open Forum Infect Dis. 2017; 4(4):ofx200. PMID: 29766015; PMCID: PMC5946886.
      Citations: 17     
    32. Nguyen AB, Chung BB, Sayer G, Mullane K, Uriel N. Acute Myocarditis Secondary to Reactivated Chromosomally-Integrated Human Herpesvirus 6. J Card Fail. 2017 07; 23(7):576-577. PMID: 28522239; PMCID: PMC5745162.
      Citations:    Fields:    Translation:HumansCells
    33. Fedorak RN, Mullane KM, Stoutenburgh U, Jin M, Adedoyin A, Chesnel L, Guris D, Larson KB, Murata Y, Boix V, Pesant Y. Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection. Open Forum Infect Dis. 2017; 4(1):ofw275. PMID: 28480267; PMCID: PMC5414029.
      Citations: 19     
    34. Mullane KM, Nuss C, Ridgeway J, Prichard MN, Hartline CB, Theusch J, Mommeja-Marin H, Larson RA. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. Transpl Infect Dis. 2016 Oct; 18(5):785-790. PMID: 27481400.
      Citations: 6     Fields:    Translation:HumansCells
    35. Zhang L, Gui XE, Wang B, Fan JY, Cao Q, Mullane K, Liang XL. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis. 2016 08 12; 16(1):408. PMID: 27515176; PMCID: PMC4982401.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    36. Lee CH, Patino H, Stevens C, Rege S, Chesnel L, Louie T, Mullane KM. Surotomycin versus vancomycin for Clostridium difficile infection: Phase 2, randomized, controlled, double-blind, non-inferiority, multicentre trial. J Antimicrob Chemother. 2016 10; 71(10):2964-71. PMID: 27432604.
      Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
    37. Dubberke ER, Mullane KM, Gerding DN, Lee CH, Louie TJ, Guthertz H, Jones C. Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open Forum Infect Dis. 2016 Sep; 3(3):ofw133. PMID: 27703995; PMCID: PMC5047394.
      Citations: 29     
    38. Marty FM, Ostrosky-Zeichner L, Mullane KM, Perfect JR, Thompson GR, Alangaden GJ, Brown JM, Fredricks DN, Herbrecht R, Klimko N, Klyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Rahav G, Santos R, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, Vehreschild MJGT, VITAL and FungiScope Mucormycosis Investigators, Cornely OA, Heinz WJ, Rácil Z, Schwartz S. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016 Jul; 16(7):828-837. PMID: 26969258.
      Citations: 230     Fields:    Translation:HumansAnimalsCTClinical Trials
    39. Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS, PUNCH CD Investigators. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study. Clin Infect Dis. 2016 Mar 01; 62(5):596-602. PMID: 26565008.
      Citations: 56     Fields:    Translation:HumansCellsCTClinical Trials
    40. Neofytos D, Railkar R, Mullane KM, Fredricks DN, Granwehr B, Marr KA, Almyroudis NG, Kontoyiannis DP, Maertens J, Fox R, Douglas C, Iannone R, Kauh E, Shire N. Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One. 2015; 10(6):e0129022. PMID: 26107507; PMCID: PMC4480423.
      Citations: 21     Fields:    Translation:HumansAnimals
    41. Weiss K, Louie T, Miller MA, Mullane K, Crook DW, Gorbach SL. Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea. BMJ Open Gastroenterol. 2015; 2(1):e000028. PMID: 26462279; PMCID: PMC4599152.
      Citations: 6     Fields:    
    42. Mullane K, Lee C, Bressler A, Buitrago M, Dabovic K, Praestgaard J, Leeds JA, Blais J, Pertel P, Weiss K. Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections. Antimicrob Agents Chemother. 2015 Mar; 59(3):1435-40. PMID: 25534727; PMCID: PMC4325808.
      Citations: 35     Fields:    Translation:HumansCells
    43. Bhansali SG, Mullane K, Ting LS, Leeds JA, Dabovic K, Praestgaard J, Pertel P. Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections. Antimicrob Agents Chemother. 2015 Mar; 59(3):1441-5. PMID: 25534724; PMCID: PMC4325791.
      Citations: 12     Fields:    Translation:HumansCells
    44. Ullmann AJ, Stoelben S, Richard MP, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Stobernack HP, Lischka P, Zimmermann H, Champlin RE, Ehninger G, AIC246 Study Team, Chemaly RF, Bornhäuser M, Kölling K, Rübsamen-Schaeff H. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med. 2014 May 08; 370(19):1781-9. PMID: 24806159.
      Citations: 102     Fields:    Translation:HumansCTClinical Trials
    45. Mullane K. Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance. Ther Adv Chronic Dis. 2014 Mar; 5(2):69-84. PMID: 24587892; PMCID: PMC3926343.
      Citations: 22     
    46. Miller MA, Fantin BR, Mullane KM, Kean Y, Gorbach SL, Cornely OA. Reply to M.R. Green et al. J Clin Oncol. 2013 Dec 01; 31(34):4379. PMID: 24166523.
      Citations:    Fields:    Translation:HumansCells
    47. Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Boeckh M, CMX001-201 Clinical Study Group, Momméja-Marin H. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013 Sep 26; 369(13):1227-36. PMID: 24066743.
      Citations: 110     Fields:    Translation:HumansCells
    48. Assi M, Martin S, Wheat LJ, Hage C, Freifeld A, Avery R, Baddley JW, Vergidis P, Miller R, Andes D, Young JA, Hammoud K, Huprikar S, McKinsey D, Myint T, Garcia-Diaz J, Esguerra E, Kwak EJ, Morris M, Mullane KM, Prakash V, Burdette SD, Sandid M, Dickter J, Ostrander D, Antoun SA, Kaul DR. Histoplasmosis after solid organ transplant. Clin Infect Dis. 2013 Dec; 57(11):1542-9. PMID: 24046304; PMCID: PMC3814825.
      Citations: 48     Fields:    Translation:Humans
    49. Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults. J Infect Dis. 2013 Nov 01; 208(9):1375-85. PMID: 23908479.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    50. Chaparro-Rojas F, Mullane KM. Emerging therapies for Clostridium difficile infection - focus on fidaxomicin. Infect Drug Resist. 2013; 6:41-53. PMID: 23843696; PMCID: PMC3702225.
      Citations: 13     
    51. Mullane KM, Cornely OA, Crook DW, Golan Y, Louie TJ, Miller MA, Josephson MA, Gorbach SL. Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials. Am J Nephrol. 2013; 38(1):1-11. PMID: 23796582.
      Citations: 26     Fields:    Translation:HumansCells
    52. Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol. 2013 Jul 01; 31(19):2493-9. PMID: 23715579.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    53. Macomber MW, Mullane KM, Liauw SL. Herpes zoster and radiation therapy: what radiation oncologists need to know about diagnosing, preventing, and treating herpes zoster. Pract Radiat Oncol. 2014 Jan-Feb; 4(1):58-64. PMID: 24621425.
      Citations: 3     Fields:    Translation:Humans
    54. Miller MA, Louie T, Mullane K, Weiss K, Lentnek A, Golan Y, Kean Y, Sears P. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013 Mar 25; 13:148. PMID: 23530807; PMCID: PMC3618004.
      Citations: 59     Fields:    Translation:Humans
    55. Estes R, Theusch J, Beck A, Pitrak D, Mullane KM. Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm. Antimicrob Agents Chemother. 2013 Apr; 57(4):1998-2000. PMID: 23403427; PMCID: PMC3623312.
      Citations: 5     Fields:    Translation:Cells
    56. Nerandzic MM, Mullane K, Miller MA, Babakhani F, Donskey CJ. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection. Clin Infect Dis. 2012 Aug; 55 Suppl 2:S121-6. PMID: 22752860; PMCID: PMC3388028.
      Citations: 58     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    57. Mullane KM, Miller MA, Weiss K, Lentnek A, Golan Y, Sears PS, Shue YK, Louie TJ, Gorbach SL. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011 Sep; 53(5):440-7. PMID: 21844027; PMCID: PMC3156139.
      Citations: 81     Fields:    Translation:HumansCells
    58. Mullane KM, Gorbach S. Fidaxomicin: first-in-class macrocyclic antibiotic. Expert Rev Anti Infect Ther. 2011 Jul; 9(7):767-77. PMID: 21810048.
      Citations: 15     Fields:    Translation:HumansCells
    59. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK, OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011 Feb 03; 364(5):422-31. PMID: 21288078.
      Citations: 553     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    60. Mezhir JJ, Mullane KM, Zarling J, Satoskar R, Pai RK, Roggin KK. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease. Surg Infect (Larchmt). 2009 Oct; 10(5):447-51. PMID: 19485785.
      Citations: 8     Fields:    Translation:HumansAnimals
    61. Louie T, Miller M, Donskey C, Mullane K, Goldstein EJ. Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection. Antimicrob Agents Chemother. 2009 Jan; 53(1):223-8. PMID: 18955525; PMCID: PMC2612138.
      Citations: 33     Fields:    Translation:HumansCellsCTClinical Trials
    62. Mullane K, Toor AA, Kalnicky C, Rodriguez T, Klein J, Stiff P. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections. Transpl Infect Dis. 2007 Jun; 9(2):89-96. PMID: 17461992.
      Citations: 8     Fields:    Translation:Humans
    63. Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplant. 2007 Apr; 39(7):425-9. PMID: 17310132.
      Citations: 41     Fields:    Translation:Humans
    64. Greenberg RN, Mullane K, van Burik JA, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006 Jan; 50(1):126-33. PMID: 16377677; PMCID: PMC1346806.
      Citations: 123     Fields:    Translation:HumansAnimals
    65. Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia. Eur J Clin Microbiol Infect Dis. 2005 Oct; 24(10):654-61. PMID: 16261306.
      Citations: 44     Fields:    Translation:HumansAnimalsCTClinical Trials
    66. Haire WD, Deitcher SR, Mullane KM, Jaff MR, Firszt CM, Schulz GA, Schuerr DM, Schwartz LB, Mouginis TL, Barton RP. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Thromb Haemost. 2004 Sep; 92(3):575-82. PMID: 15351854.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    67. Johnson S, Patel M, Mullane K. Pseudo-SARS. N Engl J Med. 2003 Aug 14; 349(7):709-11; author reply 709-11. PMID: 12917312.
      Citations:    Fields:    Translation:HumansPHPublic Health
    68. Shapiro RA, Mullane KM, Camras L, Flowers C, Sutton S. Clinical and magnetic resonance imaging regression of progressive multifocal leukoencephalopathy in an AIDS patient after intensive antiretroviral therapy. J Neuroimaging. 2001 Jul; 11(3):336-9. PMID: 11462308.
      Citations:    Fields:    Translation:Humans
    69. Farinpour R, Martin EM, Seidenberg M, Pitrak DL, Pursell KJ, Mullane KM, Novak RM, Harrow M. Verbal working memory in HIV-seropositive drug users. J Int Neuropsychol Soc. 2000 Jul; 6(5):548-55. PMID: 10932474.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    70. Martin EM, Pitrak DL, Novak RM, Pursell KJ, Mullane KM. Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. J Clin Exp Neuropsychol. 1999 Oct; 21(5):730-5. PMID: 10572290.
      Citations: 11     Fields:    Translation:Humans
    71. Pitrak DL, Sutton SH, Tsai HC, Mullane KM, Pau AK. Reversal of accelerated neutrophil apoptosis and restoration of respiratory burst activity with r-metHuG-CSF (Filgrastim therapy in patients with AIDS. AIDS. 1999 Feb 25; 13(3):427-9. PMID: 10199239.
      Citations: 1     Fields:    Translation:HumansCells
    72. Pitrak DL, Mullane KM, Bilek ML, Stevens P, Allen RC. Impaired phagocyte oxidative capacity in patients with human immunodeficiency virus infection. J Lab Clin Med. 1998 Oct; 132(4):284-93. PMID: 9794699.
      Citations: 6     Fields:    Translation:HumansCells
    73. Martin EM, Pitrak DL, Pursell KJ, Andersen BR, Mullane KM, Novak RM. Information processing and antiretroviral therapy in HIV-1 infection. J Int Neuropsychol Soc. 1998 Jul; 4(4):329-35. PMID: 9656606.
      Citations: 6     Fields:    Translation:HumansCells
    74. Bartok JA, Martin EM, Pitrak DL, Novak RM, Pursell KJ, Mullane KM, Harrow M. Working memory deficits in HIV-seropositive drug users. J Int Neuropsychol Soc. 1997 Sep; 3(5):451-6. PMID: 9322404.
      Citations: 13     Fields:    Translation:HumansCells
    75. Pitrak DL, Tsai HC, Mullane KM, Sutton SH, Stevens P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest. 1996 Dec 15; 98(12):2714-9. PMID: 8981916; PMCID: PMC507735.
      Citations: 38     Fields:    Translation:HumansCells
    76. Martin EM, Pitrak DL, Pursell KJ, Mullane KM, Novak RM. Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc. 1995 Nov; 1(6):575-80. PMID: 9375245.
      Citations: 9     Fields:    Translation:HumansCells
    77. Young MA, Henry C, Wong S, Bullough D, Mullane K. Acadesine reduces the frequency of coronary artery reocclusion following rt-PA induced thrombolysis in the dog. Thromb Haemost. 1995 Nov; 74(5):1348-52. PMID: 8607121.
      Citations: 2     Fields:    Translation:Animals
    78. Anderson KM, Petrik D, Mullane K, Harris JE. Spontaneous chemiluminescence of ETYA (5,8,11,14-eicosatetraynoic acid) is inhibited by catalase or peroxidase. Prostaglandins Leukot Essent Fatty Acids. 1994 Oct; 51(4):271-5. PMID: 7846095.
      Citations: 1     Fields:    Translation:HumansCells
    79. Bullough DA, Zhang C, Montag A, Mullane KM, Young MA. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. J Clin Invest. 1994 Oct; 94(4):1524-32. PMID: 7929829; PMCID: PMC295300.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    80. Levens NR, Ksander GM, Zimmerman MB, Mullane KM. Thromboxane synthase inhibition enhances action of converting enzyme inhibitors. Hypertension. 1989 Jan; 13(1):51-62. PMID: 2910814.
      Citations: 2     Fields:    Translation:Animals
    81. Mullane K. Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res. 1989; 301:39-51. PMID: 2678130.
      Citations: 15     Fields:    Translation:AnimalsCells
    82. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann N Y Acad Sci. 1988; 524:103-21. PMID: 2837948.
      Citations: 24     Fields:    Translation:HumansCells
    Mullane's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (341)
    Co-Authors (15)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors